Cpwm, LLC Omeros Corp Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Omeros Corp stock. As of the latest transaction made, Cpwm, LLC holds 716,886 shares of OMER stock, worth $5.44 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

716,886

Previous 471,601 52.01%

Holding current value

$5.44 Million

Previous $1.3 Million 74.09%

% of portfolio

0.21%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.09 - $7.46 $757,930 - $1.83 Million	245,285 Added 52.01%	716,886 $2.26 Million
Q2 2022 Aug 12, 2022	SELL	$1.92 - $6.28 $577,009 - $1.89 Million	-300,526 Reduced 38.92%	471,601 $1.3 Million
Q1 2022 May 13, 2022	BUY	$5.07 - $7.2 $369,308 - $524,462	72,842 Added 10.42%	772,127 $4.64 Million
Q3 2021 Nov 12, 2021	BUY	$13.4 - $16.3 $123,588 - $150,334	9,223 Added 1.34%	699,285 $9.64 Million
Q2 2021 Aug 13, 2021	BUY	$14.81 - $19.13 $347,812 - $449,268	23,485 Added 3.52%	690,062 $10.2 Million
Q1 2021 May 14, 2021	SELL	$14.52 - $23.53 $112,994 - $183,110	-7,782 Reduced 1.15%	666,577 $11.9 Million
Q4 2020 Feb 12, 2021	SELL	$10.14 - $15.19 $49,037 - $73,458	-4,836 Reduced 0.71%	674,359 $9.63 Million
Q3 2020 Nov 13, 2020	SELL	$9.57 - $21.32 $45,572 - $101,525	-4,762 Reduced 0.7%	679,195 $6.86 Million
Q2 2020 Aug 13, 2020	SELL	$12.21 - $16.99 $182,930 - $254,544	-14,982 Reduced 2.14%	683,957 $10.1 Million
Q1 2020 May 11, 2020	SELL	$9.03 - $19.72 $70,452 - $153,855	-7,802 Reduced 1.1%	698,939 $9.35 Million
Q4 2019 Feb 12, 2020	SELL	$13.01 - $17.15 $5,204 - $6,859	-400 Reduced 0.06%	706,741 $9.96 Million
Q2 2019 Aug 02, 2019	SELL	$15.0 - $19.62 $221,895 - $290,238	-14,793 Reduced 2.05%	707,141 $11.1 Million
Q1 2019 May 06, 2019	SELL	$11.65 - $17.72 $42,103 - $64,040	-3,614 Reduced 0.5%	721,934 $12.5 Million
Q4 2018 Feb 08, 2019	SELL	$10.72 - $16.73 $744,064 - $1.16 Million	-69,409 Reduced 8.73%	725,548 $8.08 Million
Q3 2018 Nov 13, 2018	SELL	$17.73 - $26.69 $466,192 - $701,786	-26,294 Reduced 3.2%	794,957 $19.4 Million
Q2 2018 Dec 21, 2018	SELL	$10.79 - $24.44 $2.73 Million - $6.19 Million	-253,292 Reduced 23.57%	821,251 $14.9 Million
Q2 2018 Aug 09, 2018	BUY	$10.79 - $24.44 $2.43 Million - $5.51 Million	225,394 Added 26.54%	1,074,543 $19.5 Million
Q1 2018 Dec 21, 2018	SELL	$9.0 - $20.16 $1.57 Million - $3.52 Million	-174,379 Reduced 17.04%	849,149 $9.49 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $537,561 - $1.2 Million	-59,729 Reduced 5.51%	1,023,528 $11.4 Million
Q4 2017 Feb 02, 2018	SELL	$13.26 - $22.86 $60,598 - $104,470	-4,570 Reduced 0.42%	1,083,257 $21 Million
Q3 2017 Nov 14, 2017	SELL	$19.76 - $24.9 $504,788 - $636,095	-25,546 Reduced 2.29%	1,087,827 $23.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,113,373	1,113,373 $22.2 Million

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $476M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account